Recombinant Human SNCA Pre-formed Fibrils Protein，His

SNCA pre-formed fibrils (PFFs) have garnered significant attention in neuroscientific research due to their role in the pathogenesis of neurodegenerative disorders, particularly Parkinson's disease. Alpha-synuclein (SNCA), a presynaptic protein predominantly found in the brain, is implicated in synaptic function and neurotransmitter release. However, misfolding and aggregation of SNCA into fibrillar structures are linked to neurotoxicity and neuronal cell death, hallmark features of Parkinson's disease. The generation of recombinant SNCA pre-formed fibrils provides a valuable tool for studying the molecular mechanisms underlying alpha-synuclein aggregation and its pathological effects. Researchers can use these PFFs to induce aggregation in cellular and animal models, thus facilitating the exploration of disease progression, potential biomarkers, and therapeutic targets. Furthermore, the study of SNCA PFFs can shed light on the propagation of misfolded proteins across neural networks, enhancing our understanding of intercellular transmission of neurodegenerative conditions. Insights gained from this research may lead to the development of novel strategies for intervention and treatment, addressing the urgent need for effective therapies for patients affected by Parkinson's disease and related synucleinopathies. Overall, SNCA pre-formed fibrils represent a critical focus area in efforts to unravel the complexities of protein misfolding and aggregation in neurodegenerative diseases, bridging basic science with translational research.